Sponsor

The George Institute

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name The George Institute appears in 34 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials34
Recruiting shown4
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

34 shown
Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform TrialNCT06352619 · lead sponsor · 2024-10-11
RECRUITING
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 DiabetesNCT05345327 · lead sponsor · 2023-01-01
RECRUITING
Optimised Treatment for Hypertension TrialNCT06935760 · lead sponsor · 2025-08-28
NOT_YET_RECRUITING
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosisNCT05752279 · lead sponsor · 2024-03-14
COMPLETED
The RAFT ECT StudyNCT05402657 · lead sponsor · 2023-03-22
COMPLETED
Polydiuretic Therapy for HFpEF, a Randomised Controlled TrialNCT05129722 · lead sponsor · 2022-10-01
TERMINATED
SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following BirthNCT05752955 · lead sponsor · 2022-06-06
COMPLETED
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERyNCT04904536 · lead sponsor · 2022-03-10
ACTIVE_NOT_RECRUITING
Preventing Adverse Cardiac Events in COPDNCT03917914 · lead sponsor · 2020-06-30
COMPLETED
Global Kidney Patient Trials NetworkNCT04389827 · lead sponsor · 2020-05-05
COMPLETED
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-StudyNCT03785067 · lead sponsor · 2020-02-27
TERMINATED
The Effects on Blood Pressure of Salt Substitute Among Adults With Hypertension in IndiaNCT03909659 · lead sponsor · 2019-11-25
COMPLETED
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-studyNCT03783754 · lead sponsor · 2018-08-09
TERMINATED
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts TrialNCT02699645 · lead sponsor · 2017-09-28
COMPLETED
Lifestyle Intervention IN Gestational Diabetes (LIVING)NCT03305939 · lead sponsor · 2017-08-01
COMPLETED
Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) StudyNCT02261727 · lead sponsor · 2014-06-01
COMPLETED
Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)NCT01422616 · lead sponsor · 2012-03-01
COMPLETED
Changing Population Salt Consumption in Lithgow, AustraliaNCT02105727 · lead sponsor · 2011-03-01
COMPLETED
Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational StudyNCT00949286 · lead sponsor · 2010-01-01
COMPLETED
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage TrialNCT00716079 · lead sponsor · 2008-09-01
COMPLETED
A Clinical Trial of IntensiVE DialysisNCT00649298 · lead sponsor · 2008-05-01
COMPLETED
Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)NCT00263393 · lead sponsor · 2005-12-01
COMPLETED
China Salt Substitute StudyNCT00145756 · lead sponsor · 2004-05-01
COMPLETED
Prevention of Ectopic Bone Related Pain and Disability After Hip Replacement Surgery With Peri-Operative IbuprofenNCT00145730 · lead sponsor · 2002-02-01
COMPLETED
Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 DiabetesNCT00145925 · lead sponsor · 2001-06-01
COMPLETED
HFrEF Polypill in Sri Lanka RCTNCT07569640 · collaborator · 2026-08-17
RECRUITING
Working Out M0 Bipolar Androgen TherapyNCT06594926 · collaborator · 2024-08-14
RECRUITING
A Combination Triple Pill Implementation Strategy for Blood Pressure cONtrolNCT07784647 · collaborator · 2026-04-01
COMPLETED
Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri LankaNCT06831864 · collaborator · 2025-02-15
COMPLETED
Polypill Versus Metformin in New Onset Type 2 DiabetesNCT05833958 · collaborator · 2024-09-01
WITHDRAWN
SMARThealth Pregnancy: Feasibility & Acceptability of a Complex Intervention for High-risk Pregnant Women in Rural India.NCT03968952 · collaborator · 2019-10-01
COMPLETED
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular PreventionNCT04082091 · collaborator · 2019-09-01
UNKNOWN
Protocol for a Multicentre Survey of Patients With Treatment Resistant HypertensionNCT03078244 · collaborator · 2016-11-01
COMPLETED
Prevention of Serious Adverse Events Following AngiographyNCT01467466 · collaborator · 2013-10-07
COMPLETED

Drugs studied in this sponsor's trials

12 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing The George Institute as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
metformin2
placebo2
acetylcysteine1
atorvastatin1
bisoprolol1
dapagliflozin1
ibuprofen1
placebo Oral Tablet1
metformin RxCUI 6809 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 2 trials placebo RxCUI 8375 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials acetylcysteine RxCUI 197 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial atorvastatin RxCUI 83367 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial bisoprolol RxCUI 19484 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dapagliflozin RxCUI 1488564 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial ibuprofen RxCUI 5640 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial placebo Oral Tablet RxCUI 375221 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial Plasma-lyte 148 RxCUI 33829 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial prednisone RxCUI 8640 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial testosterone enanthate RxCUI 37859 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial theophylline RxCUI 10438 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor25
collaborator9
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.